Latest News for: endocrine

Edit

ENHERTU® Approved in China as First HER2 Directed Medicine for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies (Daiichi Sankyo Co Ltd)

Public Technologies 25 Dec 2025
Press Release ENHERTU®Approved in China as First HER2 Directed Medicine for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies.
Edit

Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine ...

Fairbanks Daily News-Miner 18 Dec 2025
Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast Cancer and Rare Disease Settings ... .
Edit

Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine Therapy Category (Atossa Therapeutics Inc)

Public Technologies 17 Dec 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 128493218) .
Edit

Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine Therapy Category

PR Newswire 17 Dec 2025
Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast Cancer and Rare Disease Settings ... in the Precision Endocrine Therapy category.
Edit

Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on ...

Nasdaq Globe Newswire 10 Dec 2025
Lexicon Pharmaceuticals announces publication of preclinical data in the Journal of the Endocrine Society ... .
Edit

Endocrine disruptors: exposure to methylparaben and bisphenol S during pregnancy may be associated with behavioral disorders in children (Inserm - Institut National de la santé et de la recherche médicale)

Public Technologies 10 Dec 2025
The research team examined the behavioral impacts of exposure to twelve substances suspected or known to be endocrine disruptors during pregnancy (illustrative image) ... bisphenol S, a known endocrine ...
Edit

Oman Summit for Diabetes & Endocrine Across the Lifespan 2025 begins

Times of Oman 04 Dec 2025
Muscat. The Oman Summit for Diabetes & Endocrine Across the Lifespan 2025 began on Thursday in Muscat Governorate.The opening ceremony was held under ....
Edit

Summit for diabetes and endocrine across lifespan begins

Oman Observer 04 Dec 2025
MUSCAT. The Oman Summit for Diabetes and Endocrine Across the Lifespan 2025 began on Thursday in Muscat Governorate.The opening ceremony was held under the auspices of HH Sayyidah ....
Edit

Asparagine endopeptidase prompts breast cancer–related pericardial calcification by regulating IGF2 and integrin αvβ5

PNAS 04 Dec 2025
Our study reveals a significantly positive correlation ... .
Edit

Outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for pethoxamid in light of confirmatory information on the endocrine disruption assessment (EFSA - European Food Safety Authority)

Public Technologies 01 Dec 2025
) Outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for pethoxamid in light of confirmatory information on the endocrine disruption assessment. Published.. 1 December 2025. Approved. ... Share ... Meta data.
Edit

Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium

PR Newswire 01 Dec 2025
The data highlight ATNM-400's potential to address critical unmet needs in patients who have exhausted treatment options following endocrine therapy or HER2-targeted therapy failure.
Edit

Lynkuet™ (elinzanetant) approved in the EU for the treatment of moderate to severe vasomotor symptoms associated with menopause or endocrine therapy for breast cancer (Bayer AG)

Public Technologies 19 Nov 2025
Lynkuet™ (elinzanetant) approved in the EU for the treatment of moderate to severe vasomotor symptoms associated with menopause or endocrine therapy for breast cancer ... Accurate prediction of response to endocrine therapy in breast cancer patients.
Edit

Outcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology and ecotoxicology related to endocrine disruptors (EFSA - European Food Safety Authority)

Public Technologies 06 Nov 2025
) Outcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology and ecotoxicology related to endocrine disruptors.
Edit

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ ...

The Facts 05 Nov 2025
A PDF of the release can be found here ....
Edit

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer Symposium

PR Newswire 05 Nov 2025
The Endocrine Activity Index is known in the scientific literature as the Sensitivity to Endocrine Therapy (SET) Test ... The Endocrine Activity Index (EAI) test measures endocrine activity in stage II-III, HR+HER2- breast cancer.

Article Search

tools
×
×
×
×